Petrucelli N, Daly MB, Pal T (2023) BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle [cited 2024 Oct 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1247/

Evans DGR, Howell A. Breast cancer risk-assessment models. Breast Cancer Res BCR. 2007;9:213.

Article  PubMed  Google Scholar 

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst. 2004;96:1856–65.

Article  CAS  PubMed  Google Scholar 

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst. 2006;98:110–5.

Article  CAS  PubMed  Google Scholar 

Ritte R, Lukanova A, Tjønneland A, Olsen A, Overvad K, Mesrine S, et al. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer. 2013;132:2619–29.

Article  CAS  PubMed  Google Scholar 

Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 2012;13:1141–51.

Article  PubMed Central  Google Scholar 

Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102:680–91.

Article  PubMed  Google Scholar 

Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, et al. Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women. N Engl J Med. 2009;360:573–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

Article  PubMed  Google Scholar 

Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet Lond Engl. 2001;358:1389–99.

Article  Google Scholar 

Ban KA, Godellas CV. Epidemiology of breast cancer. Surg Oncol Clin N Am. 2014;23:409–22.

Article  PubMed  Google Scholar 

Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I, Dietz JR, et al. Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. J Clin Oncol. 2020;38:2080–106.

Article  CAS  PubMed  Google Scholar 

Cintolo-Gonzalez JA, Braun D, Blackford AL, Mazzola E, Acar A, Plichta JK, et al. Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat. 2017;164:263–84.

Article  PubMed  Google Scholar 

Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic Density and the Risk and Detection of Breast Cancer. N Engl J Med. 2007;356:227–36.

Article  CAS  PubMed  Google Scholar 

Vilmun BM, Vejborg I, Lynge E, Lillholm M, Nielsen M, Nielsen MB, et al. Impact of adding breast density to breast cancer risk models: A systematic review. Eur J Radiol. 2020;127:109019.

Article  PubMed  Google Scholar 

Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign Breast Disease and the Risk of Breast Cancer. N Engl J Med. 2005;353:229–37.

Article  CAS  PubMed  Google Scholar 

Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149:569–75.

Article  CAS  PubMed  Google Scholar 

Wen HY, Brogi E. Lobular Carcinoma in Situ. Surg Pathol Clin. 2018;11:123–45.

Article  PubMed  Google Scholar 

Roberts E, Howell S, Evans DG. Polygenic risk scores and breast cancer risk prediction. Breast Off J Eur Soc Mastology. 2023;67:71–7.

Google Scholar 

Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, et al. The Contributions of Breast Density and Common Genetic Variation to Breast Cancer Risk. JNCI J Natl Cancer Inst. 2015;107:dju397.

Article  PubMed  Google Scholar 

Zeinomar N, Chung WK. Cases in Precision Medicine: The Role of Polygenic Risk Scores in Breast Cancer Risk Assessment. Ann Intern Med. 2021;174:408–12.

Article  PubMed  Google Scholar 

Wang X, Huang Y, Li L, Dai H, Song F, Chen K. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis. Breast Cancer Res. 2018;20:18.

Article  PubMed  PubMed Central  Google Scholar 

About the Breast Cancer Risk Assessment Calculator (The Gail Model) [Internet]. Breast Cancer Risk Assess. Tool. [cited 2024 Sep 20]. Available from: https://bcrisktool.cancer.gov/about.html

Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.

Article  CAS  PubMed  Google Scholar 

NCCN Guidelines. Breast Cancer Risk Reduction. Version 1.2025. [Internet]. NCCN. [cited 2024 Sep 20]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast_risk.pdf

Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007;99:1782–92.

Article  PubMed  Google Scholar 

Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103:951–61.

Article  PubMed  PubMed Central  Google Scholar 

Banegas MP, John EM, Slattery ML, Gomez SL, Yu M, LaCroix AZ, et al. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women. JNCI J Natl Cancer Inst. 2016;109:djw215.

Article  PubMed  Google Scholar 

Vianna FSL, Giacomazzi J, Oliveira CB, Nunes LN, Caleffi M, Ashton-Prolla P, et al. Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire. Genet Mol Biol. 2019;42:232–7.

Article  PubMed  PubMed Central  Google Scholar 

Kim G, Bahl M. Assessing Risk of Breast Cancer: A Review of Risk Prediction Models. J Breast Imaging. 2021;3:144–55.

Article  PubMed  PubMed Central  Google Scholar 

Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, et al. Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia. J Clin Oncol. 2008;26:5374.

Article  PubMed  PubMed Central  Google Scholar 

Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91:1541–8.

Article  CAS  PubMed  Google Scholar 

Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23:1111–30.

Article  PubMed  Google Scholar 

Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003;40:807–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res BCR. 2012;14:R144.

Article  PubMed  Google Scholar 

Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women’s Health Initiative - Kurian - 2021 - Cancer - Wiley Online Library [Internet]. [cited 2024